Raltegravir Viatris (raltegravir potassium)
Generic
- Region
- 🇪🇺 EU
- Active substance
- raltegravir potassium
- Company
- Viatris Limited
- Status
- Application withdrawn
- Therapeutic area
- HIV Infections
- Designations
- Generic
- Application
- EMEA/H/C/005813
- ATC
- J05AJ01
- Official record
- www.ema.europa.eu
Indication
Treatment of human immunodeficiency virus (HIV-1)
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Dutrebis Withdrawn · Merck Sharp Dohme Limited
Follow Raltegravir Viatris
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.